Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009682HBVENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS47000135HHV7ENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS20059826HPVENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS20059833HPVENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS20060130HPVENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS44022497HTLV-1ENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS44010034HTLV-1ENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS44034575HTLV-1ENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TVIS44036737HTLV-1ENSG00000038427.16protein_codingVCANNoNo1462P13611
Q86W61
TCGA Plot Options
Drug Information
GeneVCAN
DrugBank IDDB08818
Drug NameHyaluronic acid
Target IDBE0004606
UniProt IDP13611
Regulation Typebinder
PubMed IDs16045811; 17363913
CitationsWu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB: The interaction of versican with its binding partners. Cell Res. 2005 Jul;15(7):483-94. doi: 10.1038/sj.cr.7290318.@@Hasegawa K, Yoneda M, Kuwabara H, Miyaishi O, Itano N, Ohno A, Zako M, Isogai Z: Versican, a major hyaluronan-binding component in the dermis, loses its hyaluronan-binding ability in solar elastosis. J Invest Dermatol. 2007 Jul;127(7):1657-63. doi: 10.1038/sj.jid.5700754. Epub 2007 Mar 15.
GroupsApproved; Vet_approved
Direct ClassificationAcylaminosugars
SMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Pathways
PharmGKBPA165958431
ChEMBL